FlashKeepers

Neurology · USMLE Step 1 · Healthcare and Nursing

USMLE Neurology: Movement Disorders

Parkinson disease, Huntington disease, and tremor disorders with their pathophysiology and distinguishing features tested on USMLE Step 1.

About this set

34 basic cards for USMLE Step 1 Neurology. Set 5 of 6 in USMLE Neurology. It opens with "What brain structure degenerates in Parkinson disease?" and "What are the four cardinal (TRAP) features of Parkinson disease?". Study it alongside the other USMLE Step 1 sets below.

34 cards · basic cards · AI-written, checked twice. Edit anything.

Study this set free Look inside first Get FlashKeepers for iPhone

Opens in your browser, no account. Get the iPhone and iPad app · Android app

What brain structure degenerates in Parkinson disease?
Show answerThe substantia nigra pars compacta (dopaminergic neurons)
What are the four cardinal (TRAP) features of Parkinson disease?
Show answerTremor (resting), Rigidity, Akinesia/bradykinesia, Postural instability
Describe the classic tremor of Parkinson disease.
Show answerA 4-6 Hz resting tremor, often described as pill-rolling, that improves with voluntary movement
What type of rigidity is classically seen in Parkinson disease?
Show answerCogwheel rigidity
What is bradykinesia?
Show answerSlowness of voluntary movement initiation and execution
What protein aggregates form Lewy bodies in Parkinson disease?
Show answerAlpha-synuclein
Describe the typical gait of a patient with Parkinson disease.
Show answerA shuffling, festinating gait with stooped posture and reduced arm swing
What term describes the reduced facial expression seen in Parkinson disease?
Show answerMasked facies (hypomimia)
What handwriting change is characteristic of Parkinson disease?
Show answerMicrographia, progressively smaller handwriting
What is the most effective first-line pharmacotherapy for Parkinson disease symptoms?
Show answerLevodopa combined with carbidopa
Why is carbidopa given together with levodopa?
Show answerIt inhibits peripheral DOPA decarboxylase, reducing peripheral dopamine conversion and side effects while increasing levodopa delivery to the brain
What neurotoxin is used to model Parkinson disease and how does it cause damage?
Show answerMPTP, which is converted by MAO-B into MPP+, a toxin that destroys dopaminergic neurons
Name two dopamine agonists used to treat Parkinson disease.
Show answerPramipexole and ropinirole
Name a MAO-B inhibitor used in Parkinson disease treatment.
Show answerSelegiline
What is the mechanism of amantadine in Parkinson disease?
Show answerIt increases dopamine release and blocks NMDA glutamate receptors

19 more cards in the app

Study this set free